# Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

> **NCT00032929** · PHASE3 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 269 (actual)

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Selegiline

## Key facts

- **NCT ID:** NCT00032929
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2002-12
- **Final completion:** —
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032929, "Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00032929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*